Skip to main content

Published locations for FDA approves IDH1 inhibitor for relapsed/refractory AML

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA approves IDH1 inhibitor for relapsed/refractory AML

User login

  • Reset your password
  • /content/fda-approves-idh1-inhibitor-relapsed/refractory-aml
  • /familypracticenews/article/170788/aml/fda-approves-idh1-inhibitor-relapsed/refractory-aml
  • /hematologynews/article/170788/aml/fda-approves-idh1-inhibitor-relapsed/refractory-aml
  • /internalmedicinenews/article/170788/aml/fda-approves-idh1-inhibitor-relapsed/refractory-aml
  • /oncologypractice/article/170788/aml/fda-approves-idh1-inhibitor-relapsed/refractory-aml
  • /hematology-oncology/article/170788/aml/fda-approves-idh1-inhibitor-relapsed/refractory-aml
  • /internalmedicine/article/170788/aml/fda-approves-idh1-inhibitor-relapsed/refractory-aml
  • /familymedicine/article/170788/aml/fda-approves-idh1-inhibitor-relapsed/refractory-aml